Title

Origins of the distortions in the base pair step adjacent to platinum anticancer drug-DNA adducts. Fundamental NMR solution studies utilizing right-handed cross-link models having 5'- and 3'-flanking residues

Document Type

Article

Publication Date

9-2-2009

Abstract

For DNA duplexes, the Lippard laboratory has shown that the XG* base pair (bp) step has a very unusual slide and shift, where G* is a G platinated at N7 by di- or monofunctional platinum anticancer drugs. One approach toward understanding the cause of this important unexpected XG* distortion is to examine single-strand (ss) oligonucleotide (oligo) models. Both duplex and ss XG*G* models of the key G*G* cross-link formed by cisplatin have the HH1 conformation with head-to-head bases. Cross-links have R canting (3'-G* H8 atom toward 5'-G*) in duplexes and L canting (5'-G* H8 atom toward 3'-G*) in ss models. However, dynamic motion in solution makes the ss features difficult to define. Thus, we employ less dynamic cross-link models such as (R,S,S,R)-BipPt(d(TG*G*)) and (R,S,S,R)-BipPt(d(pG*G*TTT)), the first examples of an HH1 conformer with R canting for ss oligos longer than d(GpG) (Bip = 2,2'-bipiperidine). In these, the 5'-T residue decreases R canting (indicating steric clashes with the 5'-G*) and the less bulky 5'-phosphate group forms a H-bond to HN-Pt (indicating that R canting allows H-bonding). We conclude that the 5'-X residue in duplex adducts changes its position from that in B form DNA to avoid steric clashes with the 5'-G* and the carrier ligand and secondarily to form a Watson-Crick base pair. These features, possibly aided by weak carrier-ligand H-bonding, lead to the relatively unusual features distinctive to the "Lippard bp step".

Publication Source (Journal or Book title)

Journal of the American Chemical Society

First Page

12314

Last Page

24

This document is currently not available here.

COinS